Introduction
Tyrosyl phosphorylation and dephosphorylation of proteins Upon receptor engagement with antigen, several CD3 chains, most notably the ζ chain, become heavily tyrosyl phosphorylcomprise key regulatory events in many signal transduction pathways leading to proliferation and differentiation. In T cells, ated which, at least in part, is catalyzed by Lck. A similar effect can be evoked by antibody cross-linking of the receptor. the TCR signals via the activation of protein tyrosine kinases (PTK). The TCR is composed of antigen-specific α and β
The resulting phosphotyrosyl residues provide docking sites for recruitment of several SH2 domain-containing proteins, chains along with several invariant chains of the CD3 complex, the γ, δ, ε and ζ chains (reviewed in 1,2). Upon antigen including the PTK Zap-70. The subsequent activation of Zap-70 leads to downstream tyrosyl phosphorylation of cellupresentation by MHC molecules, the αβ TCR binds to the antigen and intracellular signals are propagated via the lar proteins. TCR-initiated signaling pathways play a critical role in cytoplasmic tails of the CD3 chains. MHC molecules also serve as ligands for the co-receptors CD4 and CD8 on T determining thymocyte fate during development. The major developmental stages of immature T cells in the thymus are cells. These co-receptors (along with their associated PTK Lck) are concomitantly activated through their interaction with defined by the cell surface expression of the TCR and the co-receptors CD4 and CD8. Immature pre-thymocytes (which the same MHC molecule as the one recognized by the TCR. originate in the bone marrow) colonize the thymus and no obvious phenotype has been reported for heterozygotic (me/ϩ) mice. first differentiate into 'triple-negative' thymocytes that do not
We and others have previously implicated a role for SHP-1 express the TCR, CD4 or CD8. These cells then acquire low in TCR-mediated signaling. In an earlier study, we showed levels of TCR expression without the expression of CD4 or CD8 that SHP-1 becomes rapidly tyrosyl phosphorylated upon [double-negative (DN)]. Via a TCR ϩ CD4 -CD8 low transitional cross-linking of the TCR (14) . Recent studies (20,21) have stage, DN thymocytes differentiate into a double-positive (DP) demonstrated that, compared to thymocytes from normal state, in which both CD4 and CD8 are co-expressed with the mice, me/me thymocytes are hyper-responsive to TCR stimu-TCR. DP thymocytes undergo either positive selection (which lation, which is manifested by increased IL-2 production and leads to further maturation and proliferation of selected cells), hyper-proliferation in response to TCR cross-linking. A similar culminating in the production of CD4 ϩ or CD8 ϩ single-positive hyper-sensitivity of TCR-mediated signaling was demon-(SP) cells, or negative selection (which leads to cell death).
strated by overexpression of dominant negative forms of In addition to these major stages in T cell differentiation, a SHP-1 in Jurkat T cells, which also resulted in enhanced number of intermediate states of thymocyte development IL-2 production (22) . The precise target(s) of SHP-1 remain have also been defined based on the expression of other controversial. Plas et al. suggested Zap-70 as the direct surface molecules (reviewed in 3, 4) .
target of SHP-1 (22) . In contrast, our data showed that The different stages of T cell maturation in the thymus have me/me thymocytes display a prolonged activation of Lck and been elegantly studied in TCR transgenic mice (TCR Tg)
Fyn kinases and increased intracellular tyrosyl phosphorylacarrying specific TCR α and β chains (reviewed in 5). The tion of several substrates (20) . Regardless of the direct introduced TCR genes, which are expressed on almost all target(s), the above data suggest that SHP-1 is a negative immature T cells, as well as on the majority of the mature T regulator of TCR-mediated signaling and that a lack of SHP-1 cells, provide a convenient approach for following the fate of causes increased strength of TCR-mediated signals. thymocytes and mature T cells during development. Current
Since SHP-1 is implicated in negative regulation of TCRmodels suggest that the TCR of an immature thymocyte mediated signaling and the strength of the signal transmitted interacts with a putative endogenous antigen (presented by from the TCR influences T cell maturation, we tested the thymic epithelial cells) and that the avidity of this T cell-antigen hypothesis that regulation of TCR-mediated signals by SHP-1 interaction determines the fate of the maturing thymocyte.
influences thymocyte development by controlling the threshImmature T cells with TCR that have a negligible or low avidity olds for positive and/or negative selection perceived by will die due to 'neglect'. Thymocytes that express TCR of thymocytes. We hypothesized that a thymocyte expressing a moderate avidity will be positively selected for further matura-TCR of low avidity, which, due to a weak TCR signal, would tion, while those expressing TCR of high avidity for the normally be 'neglected', in the absence of SHP-1, might signal endogenous antigens will be negatively selected ('deleted') with sufficient strength to be positively selected. Similarly, a (6) (7) (8) .
thymocyte bearing a TCR of moderate avidity, which would Mice with specific defects in signaling molecules have normally be positively selected, might be deleted in the me/ provided powerful tools to examine the function of these me background due to enhanced signals via the TCR. Thus, molecules in T cell development, in particular when crossed in the me/me mouse, the 'perceived' thresholds for thymic with TCR Tg mice. For example, mice with targeted disruption positive and negative selection would be 'leftward-shifted' of the genes encoding Lck (9) or the tyrosine phosphatase with respect to antigen dose/avidity. CD45 (10) , which regulates Lck, display blocks in thymocyte Although, we and others have failed to observe any abnordevelopment, indicating the importance of these molecules malities (as assessed by surface marker expression) in overall as positive regulators of T cell maturation. Conversely, crosses thymocyte composition in me/me mice (20, 21, 23, 24) , it is between the TCR Tg and CD5-deficient mice identified CD5 important to note that analyses of a me/me thymus may not as a negative regulator of thymocyte selection process (11).
show abnormalities in a steady state since the thymocyte Although much is known about the initiation of the TCRselection process per se is not perturbed, but rather the TCR mediated signaling events, very little is known about mechanthat are selected have different avidities. If SHP-1 controls ism(s) by which TCR signaling is terminated. The tyrosine signaling thresholds, the average positively selected me/me phosphatase SHP-1, which is expressed predominantly in T cell might express a TCR with lower avidity than the average hematopoietic cells, has been implicated in negative regulain a normal mouse. Such an effect would not easily be revealed tion of signaling events induced by receptors for cytokines, in me/me mice expressing a large variety of unidentified TCR. growth factors and antigens (12, 13) . SHP-1 is composed of However, a role for SHP-1 in thymocyte selection might be a central catalytic domain, two Src-homology 2 (SH2) domains detectable if the majority of the thymocytes express a single at its N-terminus and a C-terminus with tyrosyl phosphorylation TCR of a defined affinity (e.g. in a TCR transgenic mouse). sites (14) . The best evidence for a critical role for SHP-1
Based on this rationale, we adopted a genetic approach, in vivo has come from the motheaten mouse, a naturally which allowed us to follow the fate of thymocytes in a controlled existing genetic model for SHP-1 deficiency (15-17). Mice fashion by monitoring thymocyte populations in which the homozygotic for the motheaten (me/me) mutation at the SHP-1 majority of cells express a specific Tg TCR, in wild-type (ϩ/ locus express no detectable SHP-1 protein. These mice have ϩ), heterozygotic (me/ϩ) or homozygotic motheaten (me/me) proven to be a valuable tool for genetic studies to probe the backgrounds. We crossed DO11.10 TCR transgenic mice, in vivo functions of SHP-1 (18,19). The me/me mice display which express a TCR specific for chicken ovalbumin (OVA) peptide (25) onto the motheaten background. Analyses of a multitude of disorders in all hematopoietic lineages. To date, thymocytes from the progeny of these mice demonstrates 10 mM NaF) containing leupeptin (10 µg/ml), aprotinin (1 µg/ ml), pepstatin A (1 µg/ml), antipain (1 µg/ml) and PMSF (20 that SHP-1 regulates both positive and negative selection. Data obtained from expression of a dominant negative mutant µg/ml). Cell lysates were clarified by centrifugation for 30 min at 100,000 g at 4°C. Then 3 µg of affinity-purified polyclonal of SHP-1 in the BYDP hybridoma cell line confirm that SHP-1 helps to control TCR responsiveness in a cell-autonomous rabbit anti-SHP-1 antibodies (14) was added to cleared lysates for 2 h at 4°C. Immune complexes were collected by manner and suggest that one way SHP-1 negatively regulates TCR signaling might be via the regulation of Lck activity.
adding 50 µl of Protein A-Sepharose (Amersham Pharmacia Biotech, Piscataway, NJ) for 30 min at 4°C, followed by five washes with lysis buffer. Samples were resolved by SDSMethods PAGE and electroblotted onto Immobilon P (Millipore, Bedford, MA). Immunoblots were blocked for 1 h at room temperature Cell culture and generation of cell lines with 5% dry milk in TBST (10 mM Tris-HCl, pH 8.0, 150 mM BYDP cells (26) and A20 cells (obtained from T. Braciale, NaCl and 0.05% Tween 20) before primary antibodies (antiUniversity of Virginia) were grown in RPMI 1640 medium SHP-1, polyclonal serum) were added at 1:1000 dilution for supplemented with 10% FCS, 5ϫ10 -5 M 2-mercaptoethanol, 1 h. After three washes in TBST, secondary antibodies (1:7500 2 mM L-glutamine, and antibiotics (complete medium). Stable dilution; anti-rabbit-horseradish peroxidase; Amersham Pharcell lines were generated by co-transfecting BYDP cells with macia Biotech) were added for 1 h. After another five washes, the expression vector pEBG alone or pEBG constructs, into immunoblots were developed using enhanced chemilumineswhich wild-type or mutant SHP-1 had been inserted, together cence (ECL; Amersham Pharmacia Biotech). with the plasmid pMHneo (27), which confers G418 resistance. pEBG (28) drives expression of glutathione-S-transferase
Lck kinase assays (GST)-tagged proteins under the control of the elongation BYDP cells (5ϫ10 6 ) were stimulated as described previously factor 1-α promoter. Wild-type SHP-1 (SHP-1 wt) and a mutant (14) with anti-CD3 (1 µg/ml) plus anti-CD4 (1 µg/ml) antibodies of SHP-1 containing a deletion in its phosphatase domain for the indicated times. Stimulated cells were lysed in 0. 4 and 10 mM NaF) containing leupeptin (10 µg/ml), vector was used as a control. Clones were selected for G418 aprotinin (1 µg/ml), pepstatin A (1 µg/ml), antipain (1 µg/ml) resistance (1.5 mg/ml) and expression of exogenous SHP-1 and PMSF (20 µg/ml). CD4-associated Lck was immunoprewas confirmed by immunoprecipitation followed by immunobcipitated from clarified lysates, prepared as described above, lotting. At least five independent clones were generated for by adding 50 µl of Protein A-Sepharose for 1 h. The immune each construct, three of which were analyzed in detail and complexes were washed 3 times in wash buffer (20 mM displayed similar phenotypes. Data for a representative set HEPES, pH 7.4, 150 mM NaCl, 1 mM Na 3 VO 4 and 5 mM NaF) of clones are shown in Fig. 1 .
and once in kinase reaction buffer (5 mM HEPES, pH 7.4, 5 Mice mM p-nitrophenyl phosphate and 10 mM MnCl 2 ). Kinase reactions were performed in a total volume of 25 µl of kinase C57BL/6 me/ϩ (originally obtained from the Jackson Laboratbuffer containing 5 µCi of [γ-32 P]ATP for 10 min at 30°C. ory, Bar Harbor, ME) and DO11.10 TCR transgenic BALB/c Reaction products were resolved by SDS-PAGE, transferred (generously provided by M. McDuffie, University of Virginia) onto Immobilon P as described above and subjected to mice were bred in our colony. Genotypes were determined autoradiography. by PCR, using the primer pairs: 5Ј-GGTGACTTCTCCCTCTCA-GTCAG-3Ј and 5Ј-GTGGGGTCCGAGCAGTTCAGTG-3Ј for IL-2 assay the me allele, and 5Ј-TGGCTCTACAGTGAGTTTGGT-3Ј and Ninety-six-well plates were coated with the appropriate con-5Ј-CAGGAGGGATCCAGTGCCAGC-3Ј for the DO11.10 TCR.
centrations of anti-CD3 antibody overnight at 4°C and washed DO11.10 TCR Tg mice (ϩ/ϩ:Tg) were intercrossed with mice 3 times with PBS. BYDP-derived cell lines were plated in heterozygotic for the me allele (me/ϩ 
Flow cytometric analysis Immunoprecipitation and immunoblotting
Total thymocytes (2ϫ10 6 ) were stained with antibodies to the indicated surface markers in PBS supplemented with 3% BSA Cells (3.5ϫ10 6 ) were lysed in 0.35 ml lysis buffer (50 mM Tris-HCl, pH 7.6, 150 mM NaCl, 0.5 % NP-40, 1 mM Na 3 VO 4 , and 0.1% sodium azide (FACS juice). All antibodies were used at 2 ng/ml. CD4-phycoerythrin, CD8-FITC, V β 8-biotin scatter. For ex vivo deletion assays, 30,000 events were collected and analyses were carried out on gated live thymo-(clone MR5-2), CD69-biotin and streptavidin-CyChrome were purchased from PharMingen (San Diego, CA); CD3-biotin cytes (15-20%). and anti-mouse-FITC were purchased from Southern BiotechEx vivo deletion assay and Annexin V staining nology (Birmingham, AL). KJ1-26 was kindly provided by M.
McDuffie, University of Virginia. To analyze stained thymo-
Ex vivo deletion assays were performed following a previously described protocol (31) . Briefly, thymocytes (1ϫ10 6 ) were cocytes, 25,000 events were collected on a FACSCalibur instrument calibrated with CaliBRITE beads using CellQuest cultured with 1ϫ10 5 A20 B cells in the presence of the indicated concentrations of OVA peptide in complete medium. software for collection and subsequent analyses (Becton Dickinson, Mountain View, CA). Analyses were carried out on After 20 h, cells were harvested into FACS juice and analyzed by flow cytometry. For direct assessment of OVA peptidelive thymocytes (Ͼ95%) as defined by forward and side angle induced apoptosis, cells were harvested after 8 h, stained tested whether this was reproduced in our model system and could therefore be attributed to a hyper-sensitivity of the TCRwith PE-labeled Annexin V (PharMingen) and analyzed by flow cytometry. Gates for the analyses were set so that all CD4 co-receptor signaling pathway. BYDP cells expressing the different SHP-1 constructs were co-stimulated with antithymocytes were included but A20 cells excluded.
CD3 plus anti-CD4 and CD4-associated Lck kinase activity Proliferation assay was assayed. All three cell lines showed a similar pattern of Lck activation within 5 min following stimulation. However, the Proliferation assays were performed as described previously inactivation profile was strikingly different between these lines. (20). Briefly, for antibody stimulations, 96-well plates were
In GST alone-or GST-SHP-1 wt-expressing BYDP cells, Lck coated with the indicated concentrations of anti-CD3 antibody kinase activity was significantly diminished (by~50%) within (145-2c11; Southern Biotechnology, Birmingham, AL) over-10 min of stimulation. In contrast, the dominant negative GSTnight at 4°C and washed 3 times with PBS. Thymocytes were SHP-1 ∆P-expressing cells showed sustained Lck activity ( transgenic TCR specific for a fragment of chicken ovalbumin peptide (amino acids 323-339) in the context of I-A d . Because Results the antigen specific for the DO11.10 TCR is well defined, dose-response studies on thymocytes expressing the trans-SHP-1 is a cell-autonomous negative regulator of TCR gene can be performed to monitor TCR responsiveness either signaling in vivo or ex vivo. We noticed that some of the early generation me/ϩ:Tg and me/me:Tg mice showed several inconsistent We have previously shown that, when assayed for proliferation and IL-2 production, thymocytes from me/me mice are hyperand unusual phenotypes with respect to their thymocyte composition (data not shown). However, in later generations, responsive to TCR stimulation compared to normal thymocytes (20), suggesting hyper-sensitive TCR signal transduction as mice became increasingly congenic, the phenotypes of different animals bearing the same genotype were quite pathways. To directly assess whether there is a cell-autonomous hyper-sensitivity of TCR signaling in the absence of consistent. The observed inconsistent phenotypes in early generations were most likely due to segregating modifier loci functional SHP-1, we utilized the BYDP hybridoma line, which has been shown to mimic various aspects of thymocyte in the C57BL/6 background (present in the me/ϩ mouse used for the initial cross). Therefore, all data presented here are signaling (26). We previously used this line to define biochemical events involving SHP-1 following TCR stimulation (14) .
derived from mice of F 5 or later generations (four rounds of backcrossing; theoretically, ഛ3% genetic contribution by BYDP cell lines stably expressing GST-tagged versions of either wild-type SHP-1 (SHP-1 wt) or a phosphatase-inactive, C57BL/6). dominant negative mutant of SHP-1 (SHP-1 ∆P) were generEffects in homozygotic me/me TCR Tg mice ated. The wild-type and mutant GST-SHP-1 constructs were expressed at levels~5-fold higher than endogenous SHP-1, Thymocytes from the various mice derived from intracrosses were analyzed for their surface marker expression ( Fig. 2 and as assessed by immunoblotting (Fig. 1A) . Data of one clone for each line are shown here as a representative of at least Table 1 ). As expected from previous studies (20,21,23,24), thymuses from ϩ/ϩ:DO11.10 TCR Tg (ϩ/ϩ:Tg) mice showed three independent clones. Each line was stimulated with a range of concentrations of anti-CD3 antibody and IL-2 a normal composition with respect to the percentages of DN (CD4 -CD8 -), DP (CD4 ϩ CD8 ϩ ) and SP (CD4 ϩ CD8 -and CD4 -production was measured. As shown in Fig. 1(B) , an~2-fold lower concentration of anti-CD3 was sufficient to evoke half-CD8 ϩ ) subpopulations ( Fig. 2A) . A similar (normal) composition was observed for non-Tg thymi, independent of their maximal IL-2 production by the line expressing dominant negative SHP-1 compared to the lines expressing GST-SHP-1 genotype at the SHP-1 locus (Fig. 2D and bottom half of Table 1 ). These data are consistent with our previous or GST alone.
In our previous study, we showed that when stimulated by observation that me/me mice have overall normal thymocyte subpopulations (20). However, in our analyses of a large co-cross-linking of the TCR together with CD4, thymocytes from me/me mice displayed prolonged activation of the src number of mice, we observed that in the presence of the DO11.10 transgenic TCR, thymocytes from me/me mice family kinase Lck compared to normal thymocytes (20). We Table 1 ). Numbers represent the percentage of cells in the different regions. (E-H) CD4 versus CD3 profiles. Note that the CD4 ϩ CD3 low population in ϩ/ϩ:non-Tg mice, which is absent in the Tg mice, reflects CD4 ϩ CD8 ϩ TCR low-med thymocytes, a normal population in thymocyte development, which is missing in TCR Tg mice due to their pre-arranged TCR. (I-M) CD4 versus V β 8 profiles. The boxed regions of CD3 high or V β 8 high thymocytes correspond to the CD4 ϩ SP population. Numbers represent the percentages of cells in each indicated region.
revealed abnormalities, manifested as the following unusual to positive selection, instead is now perceived as a highavidity antigen causing deletion. These data indicate that phenotypes.
Decreased number of DP cells. Compared to ϩ/ϩ:Tg mice SHP-1 helps to set the threshold for negative selection.
Relative increase of CD4 ϩ CD8 -SP cells. Consistently, we (n ϭ 32), me/me:Tg mice (n ϭ 38) showed a dramatic decrease in the number of total thymocytes [1.5ϫ10 8 
observed that in me/me:Tg mice, there was a 2-to 4-fold increase in the percentages of CD4 ϩ SP cells (Table 1 , and versus 0.36ϫ10 8 (me/me),~24%] (Table 1) . Flow cytometric analyses revealed that this reduced cellularity was almost Fig. 2A and C) , as compared to ϩ/ϩ:Tg mice. Selection of CD4 ϩ SP cells is consistent with the MHC class II specificity entirely due to a dramatic loss of DP cells (Table 1 , and Fig.  2A and C) . Moreover, the remaining DP population in the me/ of the DO11.10 TCR, suggesting specific positive selection of these thymocytes in me/me:Tg mice. The observed relative me:Tg mice displayed decreased levels of CD4 and CD8 surface expression. The dramatic decrease in DP thymocytes, increase could be fully accounted for by the decreased total cellularity due to the dramatic loss of DP cells. Although the concomitant with the relatively constant cell numbers of the other thymic subpopulations and additional ex vivo deletion absolute number of CD4 ϩ SP cells was~70% in a me/me:Tg mouse compared to a ϩ/ϩ:Tg mouse, after normalizing for studies (see below, Fig. 4) , support the conclusion that the me/me:Tg mice display increased negative selection even the decreased body mass of the motheaten mouse (about two-thirds that of its normal littermate), the number of CD4 ϩ without exposure to specific antigen. This is consistent with our initial hypothesis that in the absence of SHP-1, an antigen SP cells was actually constant between a ϩ/ϩ:Tg and a me/ me:Tg mouse. This was interesting given that me/me:Tg mice recognized with moderate avidity, which 'normally' would lead 
Thymocytes from mice carrying the indicated genotypes were analyzed for CD4 and CD8 surface expression. The relative (%) and absolute numbers (N) of thymocytes displaying the indicated phenotype are shown. Errors represent the SEM. For easier comparison, the cell numbers of me/ϩ and me/me mice relative to the cell numbers of ϩ/ϩ mice are shown in the last column of each panel.
a The majority of the CD4 -CD8 -population in the me/me:Tg mice were CD3 ϩ and V β 8 ϩ (Fig. 3G and L) indicating that this population is different from the DN populations in mice of other genotypes.
exhibit a big loss of DP cells, some of which would 'normally' surface expression was then lost during further maturation. At the time point that thymic compositions were analyzed give rise to CD4 ϩ SP cells. It was therefore conceivable that we would also observe a loss of CD4 ϩ SP cells. Indeed, this (15-19 days post-natal), the majority of the DN cells in me/ me:Tg expressed the TCR and was therefore part of this was the case for the small population of non-transgenic TCR expressing CD8 ϩ SP cells.
unusual subpopulation, only a relatively small fraction of thymocytes were 'true' DN cells. To further characterize the thymocyte subpopulations, thymocytes were triple-stained for CD4, CD8 and CD3 (CD4 versus To analyze the thymocytes not only for expression of the transgenic V β 8 chain, but also for expression of the complete CD3; Fig. 2E-H) . The majority of the CD4 ϩ SP thymocytes in the ϩ/ϩ:Tg as well as the me/me:Tg mice were CD3 high (and transgenic TCR (α and β chain), cells were stained with KJ1-26, a clonotypic anti-DO11.10 TCR antibody (Fig. 3) . For CD69 high , data not shown), indicating that these are indeed mature, positively selected thymocytes. Analyses of TCR β ϩ/ϩ:Tg thymocytes, staining with KJ1-26 overlapped the V β 8 staining (Fig. 3A) , indicating that all of the cells express both expression on these CD4 ϩ SP cells showed that they express the transgenic V β 8 chain (CD4 versus V β 8; Fig. 2I-M ) (see the α and β chain of the transgenic TCR. With respect to V β 8 staining per se, me/me:Tg thymocytes showed an increase below for comparison with staining by KJ1-26, a clonotypic anti-DO11.10 TCR antibody which recognizes the transgenein V β 8 high and a decrease in V β 8 med staining (Fig. 3B and C) . This is consistent with the increase in CD4 ϩ SP and the specific α and β chains of the TCR).
Our results suggest that, in addition to helping to set the decrease in DP cells caused by the enhanced negative and 'leftward-shifted' positive selection in me/me:Tg mice. In threshold for negative selection, SHP-1 also plays a role in setting the threshold which determines whether a cell is general, me/me:Tg mice also displayed similar staining for V β 8 and KJ1-26. We observed some variation in different mice 'neglected' or positively selected. In the absence of SHP-1, both thresholds are lowered leading to enhanced negative with the me/me:Tg genotype, most likely due to slight genetic variations. About 50% of the me/me:Tg mice showed an selection and 'leftward-shifted' positive selection.
TCR ϩ DN cells. In addition to the relative increase in CD4 ϩ almost identical profile for V β 8 and KJ1-26 staining (Fig. 3B) , whereas the other half displayed a small decrease of KJ1-SP cells, thymocytes from me/me:Tg mice also showed añ 3-to 5-fold increase in the percentage of DN cells, which 26 med staining compared to V β 8 med (Fig. 3C ), indicating that a small portion of thymocytes from these mice expressed lack both CD4 and CD8 expression (Fig. 2 C) . Interestingly, we found that, unlike in normal mice, the majority of these medium levels of a TCR composed of the transgenic β chain paired with endogenous α chains. DN thymocytes in me/me:Tg mice were CD3 ϩ and V β 8 ϩ (Fig.  2G and L) . These data indicated that these cells were not Effects seen in heterozygotic me/ϩ TCR Tg mice 'typical' DN cells or NK cells arising in the me/me background. Since TCR expression on these cells was medium to high Interestingly, heterozygotic me/ϩ:Tg mice displayed a phenotype intermediate between ϩ/ϩ:Tg and me/me:Tg mice with and they were also CD69 high (data not shown), it is likely that these TCR ϩ DN thymocytes were positively selected or at an absolute increase in CD4 ϩ SP cells (Ͼ50%) and a 25% loss of DP cells (Table 1 ). This suggested that even a 50% least had been stimulated via the TCR, either in the absence of co-receptors or in the presence of CD4 and CD8 whose reduction of SHP-1 caused a change in the threshold for responsiveness to various dosages of OVA peptide. We chose not to administer peptide in vivo by injection since the increased numbers of macrophages in the me/me mouse would add uncontrollable variables to the experiment, such as clearance, delivery and presentation of the peptide. Instead, we performed ex vivo assays using primary thymocytes from mice of the various genotypes. Previously, it has been shown that exposure of immature thymocytes to their specific antigen ex vivo leads within a day to deletion due to negative selection (31) . We hypothesized that if SHP-1 plays a regulatory role in this process, the critical concentration of antigen needed for negative selection should be lowered in the absence of SHP-1. Thymocytes from ϩ/ϩ:Tg and me/me:Tg mice were incubated with increasing concentrations of OVA peptide in the presence of A20 cells as APC and thymic composition was examined the following day. In the absence of A20 cells, no deletion was observed at concentration ഛ100 nM. As described previously (31) in the presence of A20 cells, there was 'spontaneous deletion' even in the absence of antigen;~40-50% in the me/me:Tg and 30-40% in ϩ/ϩ:Tg thymocyte populations. Since this slightly increased deletion of me/me:Tg thymocytes is dependent on the presence of the antigen presenting A20 cell, it might have been caused by stimulation with a peptide derived from the A20 cells. In the hyper-sensitive me/me background, this stimulation could have been strong enough to cause enhanced negative selection. As shown in Fig. 4(A  and B) , thymocytes from ϩ/ϩ:Tg mice (top row of each panel in Fig. 4A ) do not show deletion of the immature CD4 ϩ CD8 ϩ DP population Ͻ7.5-10 nM OVA peptide, consistent with the previous report (31) . In contrast, me/me:Tg thymocytes (bottom row of each panel in Fig. 4A ) displayed significant OVA-specific deletion even in the 1-7.5 nM range. In this assay, negative selection can be observed not only as a decrease in the DP subpopulation, but also as a shift within stimulation of the TCR (33) . Thymocytes from ϩ/ϩ:Tg and me/ me:Tg mice were incubated with increasing concentrations of OVA peptide presented by A20 cells and induced cell death was measured directly by Annexin V staining. Again, me/ thymocyte selection. In the case of the me/ϩ mice, the absolute increase in CD4 ϩ SP cells was most likely due to me:Tg thymocytes were hyper-responsive and exhibited cell death due to negative selection at much lower concentration the only slightly reduced number of DP cells serving as precursors. In contrast in the me/me mice, the number of DP of OVA peptide than ϩ/ϩ:Tg thymocytes (Fig. 4C) . These results, showing increased negative selection in the me/me thymocytes was so strongly reduced that even a 'leftwardshifted' positive selection generated only a limited number of background confirm that SHP-1 acts in a cell-autonomous manner to set the threshold for negative selection and that in CD4 ϩ SP cells.
the absence of SHP-1, a decreased dose of antigen is needed Thymocytes from me/me mice execute negative selection at to induce cell death, i.e. a 'leftward-shift' in the dose response lowered antigen concentrations is observed. These ex vivo deletion data are fully consistent with the increased negative selection observed in vivo. The above data on DO11.10 TCR Tg mice suggested that there was a change in positive and negative thymocyte
Hyper-sensitive proliferative response of thymocytes from selection thresholds in me/me progeny compared with ϩ/ϩ me/me TCR Tg to specific antigen mice, which was observable even in the absence of the TCRspecific OVA peptide. To further test the hypothesis that SHP-
The differences in thymocyte composition between ϩ/ϩ:Tg and me/me:Tg mice suggested that negative and maybe 1 helps control positive/negative selection by regulating the strength of TCR-mediated signals, we analyzed thymocyte positive selection are affected by the absence of SHP-1 as well as a possible hyper-proliferation of the CD4 ϩ SP response to anti-CD3 stimulation. Similar to our previous observations using thymocytes from non-Tg mice (20), we subpopulation. To test the responsiveness of mature, positively selected thymocytes, we measured their proliferative observed hyper-sensitivity of the me/me thymocytes com- pared to the ϩ/ϩ or me/ϩ thymocytes, which was manifested and TCR loci provides additional genetic evidence that the two proteins act in the same pathway. by an~1.5-to 2-fold lower EC 50 (~250 versus 400 ng/ml) (Fig. 5A) . The data are presented as percentage of maximal Since the above proliferation assays had been performed with total thymocytes, intrinsic dendritic cells and macrostimulation, since the absolute values also depend on the number of responding cells. Based on the flow cytometric phages had functioned as APC for the OVA peptide. Therefore, the possibility remained that the observed hyperprofiles (see above), this number is expected to differ between mice of the various genotypes. In general, thymocytes from sensitivity of me/me thymocytes to OVA peptide was due to differences in antigen presentation, rather than actual me/me mice incorporated 1.5-2.5 times more radioactivity than ϩ/ϩ or me/ϩ thymocytes. We then asked how these hyper-sensitivity of the TCR in the me/me background.
To address this possibility, we measured proliferation of thymocytes respond to their specific antigen, the OVA peptide. Total thymocytes were incubated with increasing amounts of thymocytes in response to specific antigen presented by the same, defined wild-type APC. Total splenocytes from OVA peptide and proliferation was measured (Fig. 5B) . As in the case of anti-CD3 stimulation, me/me:Tg thymocytes were ϩ/ϩ:Tg mice were irradiated and added as APC to the transgenic thymocytes, along with increasing amounts of hyper-sensitive compared with ϩ/ϩ:Tg thymocytes, with añ 2-to 2.5-fold lower EC 50 observed (~285 versus 675 ng/ whole ovalbumin rather than OVA peptide. Whole ovalbumin was chosen as the antigen since thymocyte preparations ml). Interestingly, in contrast to anti-CD3 stimulation where ϩ/ ϩ and me/ϩ thymocytes were indistinguishable, thymocytes
were not able to respond to it, most likely due to their limited numbers of intrinsic APC (J. D. Carter and U. Lorenz, from me/ϩ mice showed an intermediate responsiveness to OVA peptide with an EC 50 between me/me and ϩ/ϩ. This unpublished observation). Thus, proliferative responses seen in this experiment were wholly dependent on added APC dosage-dependent epistatic interaction between the SHP1 Fig. 6 . Intrinsic hyper-sensitivity of TCR expressed on thymocytes from me/me DO11.10 mice. Proliferative response of ϩ/ϩ, me/ϩ and me/ me thymocytes from DO11.10 transgenic mice to increasing amounts of whole ovalbumin, presented by irradiated splenocytes from normal mice. Without addition of splenocytes, no thymocyte proliferation in response to ovalbumin could be detected. The data shown are representative of experiments repeated 7 times, each of them consisting of five to 10 mice. Error bars represent SEM. Where no error bars are visible, the error was smaller than the symbol for that point. To facilitate the evaluation of these experiments, the EC 50 s of the presented dose-response curves are shown as bar graphs.
derived from mice expressing wild-type SHP-1. Hyperenced by the signal strength mediated via the TCR led us to hypothesize that SHP-1 might play a role in this process by sensitivity of me/me thymocytes compared to ϩ/ϩ or me/ ϩ thymocytes (EC 50 s of 550 versus 1600 and 2250 ng/ml) affecting the signaling thresholds for positive and negative selection. To test our hypothesis in vivo, we used a genetic was again observed under these conditions (Fig. 6) , indicating that the antigenic stimulation of the TCR leads model and crossed the motheaten mutation into the DO11.10 transgenic TCR background. Flow cytometric analyses of to an increased signal in the absence of the negative regulator SHP-1. It is interesting that the hyper-sensitivity progeny from these crosses revealed a number of alterations in the thymocyte phenotypes in me/me:Tg mice compared to of the me/me thymocytes was more pronounced in the presence of defined wild-type APC than in the presence ϩ/ϩ:Tg mice. First, there was a greatly reduced cellularity which is at least to a large part due to a dramatic loss of DP of the intrinsic dendritic cells and macrophages (cf. Figs  5B and 6 ). This may indicate a less effective antigen thymocytes in the me/me:Tg mice. A decreased number of DP cells can have five possible reasons. (i) Thymocytes arrest presentation by me/me APC or a lower number of potential APC in me/me mice.
at the DN stage before they mature to DP cells. However, in this case, we would expect an increase in the absolute number of DN cells, which we did not observe. In contrast, the Discussion DN population was diminished (see below). (ii) Thymocytes do not expand at the DP stage. A failure to proliferate would be Based on recent studies comparing the responsiveness of thymocytes from normal and me/me thymocytes to TCR followed by a similar decrease in the number of SP cells. However, this was not detected in the me/me:Tg mice; if at stimulation (20,21,34), SHP-1 has been suggested to be a negative regulator of TCR signaling. To address whether all, me/me thymocytes seemed to hyper-proliferate (see below). (iii) A decrease in thymic precursor cells causing an the observed hyper-sensitivity to TCR stimulation was cellautonomous and directly due to the lack of SHP-1 activity, we overall diminished thymic cellularity. However, since this would affect all thymocytes the ratios between the different subpopulgenerated T cell lines which stably express wild-type or a dominant negative mutant of SHP-1. Functional studies of ations (DN, DP, CD4 ϩ SP and CD8 ϩ SP) would not be changed. (iv) Failure to express CD4 and CD8 during the these lines showed that the observed regulatory role of SHP-1 is indeed cell-autonomous and can be directly attributed to transition from DN to DP stage. It is possible that in the absence of SHP-1, a thymocyte at the transition from DN to a decrease or lack of SHP-1 activity. Remarkably when assayed for IL-2 production, the level of hyper-sensitivity DP (TCR ϩ CD4 -CD8 low ) perceives a signal mediated via the TCR as strong enough to down-regulate surface expression produced upon expression of dominant negative SHP-1 in BYDP cells (~2-fold) is comparable to the thymocyte hyperof CD4 and CD8, thereby generating TCR ϩ DN cells as described for TCR cross-linking studies of TCR ϩ CD4 -CD8 low sensitivity observed comparing proliferation of me/me and normal thymocytes (20). Furthermore, our data indicate that cells (32) . Interestingly, a TCR ϩ DN population was observed in the me/me:Tg mice (see below). Since these cells never the regulation of Lck activity, specifically of CD4-associated Lck, either directly or indirectly, is at least one mechanism by enter the DP stage, the DP population would be decreased at the same time. However, the limited number of TCR ϩ DN which SHP-1 acts as a negative regulator of TCR signaling thresholds.
cells (10 7 ) cannot by itself be the only reason for the dramatic loss in the DP population [12ϫ10 7 (ϩ/ϩ) versus 1.8ϫ10 7 (me/ These data and reports that thymocyte selection is influ-me)]. (v) Increased cell death of DP thymocytes due to down-regulate surface expression of CD4 and CD8. Such a mechanism has been observed in ex vivo studies (32). negative selection.
The DP population remaining in the me/me:Tg mice showed Another possibility is that these cells were positively selected but then down-regulated CD4 expression. Alternatively, in the a shift from CD4 high CD8 high towards CD4 low CD8 low. There are two possible causes for the appearance of such a population:
absence of SHP-1, the TCR alone could send a signal of sufficient strength to positively select cells which express (i) these thymocytes down-regulated their surface expression of CD4 and CD8 in response to a TCR-CD4 stimulation as it neither CD4 nor CD8. Under normal conditions, TCR ϩ DN would not receive a signal of sufficient strength and be was observed in the ex vivo deletion assays (Fig. 4A) or (ii) because of their low surface expression of CD4 and CD8, neglected. It is also possible, that TCR ϩ DN thymocytes represent a distinct lineage in Tg mice that accumulates these cells escaped the increased ongoing negative selection and are therefore enriched in the me/me:Tg mice. In contrast under these specific conditions, as seen previously in male HY-TCR Tg mice (37) . Further studies will be necessary to to the decreased number of DP cells, the absolute number of CD4 ϩ SP thymocytes stayed relatively constant. Moreover, distinguish between these possibilities. It is striking that the dramatic decrease of DP thymocytes an unusual TCR ϩ DN population was observed. These data, indicating increased negative selection in me/me:DO11. 10 due to negative selection observed here was not detectable in a non-Tg me/me mouse. There are two possible, not Tg mice, together with studies showing that thymocytes from these mice are hyper-sensitive to their specific antigen when mutually exclusive, reasons for this observation. (i) The number of potentially different TCR with their various avidities in examined in ex vivo deletion assays support our hypothesis that SHP-1 helps to set the threshold for negative selection a non-TCR Tg mouse might not allow us to uncover such an effect because the deleted thymocytes would be continuously and that, in its absence, the threshold is lowered.
The lack of effect on the number of CD4 ϩ SP thymocytes replaced. In contrast, in TCR Tg mice in which a major fraction of the thymocytes carry a TCR of the same avidity, an increase despite the dramatic loss of DP thymocytes can have two possible, not mutually exclusive, reasons. (i) A subpopulation in deletion would be more easily detected.
(ii) One of the differences between a Tg TCR and an endogenous TCR is of thymocytes which would have been neglected under normal conditions (in a ϩ/ϩ:Tg) was positively selected. Since these the early expression of high levels of the Tg TCR as evidenced by the absence of a TCR low population (cf. Figs 2E-G and mature CD4 ϩ SP cells were observed without exposure to the TCR-specific OVA peptide, positive selection in me/ 2H). It is conceivable that negative selection in a TCR Tg mouse occurs at an earlier developmental state within the DP me:Tg mice must have, at least partially, occurred following stimulation by endogenous peptide(s) of low avidity for the population compared to a non-TCR Tg mouse, causing a greater apparent loss of DP thymocytes. It is important to transgenic TCR. Under normal conditions, such stimulation would have led to neglect due to insufficient stimulation; stress that our data indicate that the 'normal' thymocyte composition in me/me mice only reflects the 'steady-state' however, in the absence of SHP-1, a lowered threshold for positive selection would enable antigens with 'normally' too level of the overall thymocyte population, but does not imply that TCR signaling with respect to thymocyte selection is low affinity to positively select thymocytes expressing the Tg TCR.
(ii) The CD4 ϩ SP thymocytes hyper-proliferated following normal in me/me mice. Instead our data predict the average affinity of a TCR for its antigen in me/me mice is lower than positive selection leading to a selective expansion of this subpopulation. Based on our ex vivo proliferation assays in normal mice. These differences are revealed only in the sensitized background of TCR Tg mice. which showed a hyper-sensitivity of me/me:Tg thymocytes to antigen-specific stimulation, it is conceivable that at least part
In previous studies, we and others failed to observe any abnormal/intermediate phenotype in heterozygotic me/ϩ of the decreased DP population was compensated at the CD4 ϩ SP stage by hyper-proliferation. However, cell cycle mice, indicating that one wild-type allele of SHP-1 is sufficient to produce a normal phenotype. However in this study, studies showed that the percentages of CD4 ϩ SP thymocytes in G0/G1, S and G2/M phase were similar between ϩ/ϩ, me/ we observed an intermediate phenotype for me/ϩ mice compared to ϩ/ϩ and me/me mice when analyzed for thymic ϩ and me/me DO11.10 TCR Tg mice indicating comparable in vivo proliferation (J.D.Carter and U.Lorenz, unpublished composition (Table 1 and Fig. 2) , as well as when assayed for proliferative response to its specific antigen (Figs 5 and observation). Therefore, it is very likely that the threshold for positive selection also was lowered in the absence of SHP-6). This epistatic interaction between the SHP-1 and the TCR loci provides further genetic evidence that SHP-1 and the 1, especially in the light of two very recent reports showing increased positive selection, one of which examined me/me TCR are part of the same signaling pathway. Detection of this phenotype is most likely due to the sensitized background mice expressing a MHC class I-restricted transgenic TCR (35) and one of which used mice expressing a dominant provided by the use of a TCR transgene, which allows us to reveal subtle differences in signal strengths. Similar dosage negative mutant of SHP-1 in the context of a MHC class IIrestricted transgenic TCR (36) .
effects of signaling molecules on thymocyte selection have been elegantly demonstrated by Perlmutter and colleagues In addition to the phenotypes described above, thymuses from me/me:Tg mice contained an unusual population of using different copy numbers of an Lck transgene (38) . This is particularly interesting, since our previous studies (20) and TCR ϩ DN thymocytes. There are several possible explanations for the appearance of these cells. These cells might have data present here indicate that Lck might be at least one of the targets by which SHP-1 exerts its regulatory function in been derived from a population (TCR ϩ CD4 -CD8 low ) in transition from DN to DP which, due to the absence of SHP-1, TCR signaling. In addition, the fact that we observed an intermediate received a strong enough signal mediated via the TCR to phenotype for OVA peptide stimulation, but not for antiphosphatase, CD45, has been shown to be necessary for CD3 cross-linking, emphasizes the differences between nonactivation of src family kinases (42,43). Interestingly, CD45 physiological antibody cross-linking and antigen-specific knock-out mice (10) display a phenotype almost the converse stimulation by APC. CD3 cross-linking biases towards signals of the motheaten phenotype with a strong defect in thymocyte delivered by TCR stimulation, whereas under physiological development and a minor defect in B cell development, the conditions, signals are delivered by both the TCR and the latter detectable only in the sensitized context of B cell CD4-MHC complex. The observed difference is of particular receptor transgenic mice (44) . Since it has been shown that interest since our data implicate the CD4-associated Lck as some of the B cell defects in motheaten mice can be rescued a target for SHP-1. A similar distinction was noted previously by lack of CD45 (45), it is likely that regulation of antigen in a CD45 -T cell line which was reconstituted with different receptor signaling via the downstream src family kinases is isoforms of CD45. Certain functional differences between determined both by SHP-1 and CD45. these isoforms were revealed upon antigen-specific stimula-SHP-1-deficient mice exhibit an early involution of their tion but not upon anti-TCR cross-linking (39) .
thymus, most notable in me v /me v mice. Transplantation experiInterestingly, in two recent reports which addressed the ments of normal and me v /me v bone marrow suggested that a role of SHP-1 in thymocytes development, SHP-1 seemed to homing defect of the pro-thymocytes was the cause for the regulate only positive selection but no change in negative early involution observed in motheaten mice (46) . However, our selection was observed. Most likely, these differences are data suggest an alternative or additional reason. Due to the due to the genetic background of the mice that were analyzed increased deletion in me/me mice, more thymocytes have to and the different transgenic TCR that were used. For example, flux through the thymus to sustain a normal total thymocyte Johnson et al. studied the progeny of C57BL/6J mice crossed number. Eventually, this would lead to a depletion of precursors to C57BL/10 mice in the context of a MHC class I-restricted and, if the mouse lives long enough, result in an early involution TCR (35), whereas Plas et al. analyzed progeny of cross of the thymus. This is consistent with our observation that there between C57BL/6 and B6.AKR mice using a MHC class IIare very few 'typical' DN thymocytes in me/me:Tg mice. restricted TCR (36) . In our studies, we used a MHC class IIAlthough our data demonstrate a role for SHP-1 in regulating restricted TCR in a Ͼ97 % congenic BALB/c background the thymocyte selection process, the precise molecular mechgenerated by at least five rounds of backcrosses. Since anism by which SHP-1 exerts such regulation is unclear. One the endogenous antigens which 'normally' cause positive potential, previously described binding partner for SHP-1 at selection of these transgenic TCR are unknown, it is impossible the cell surface is CD5 (21,47). Co-cross-linking of CD5 and to identify the exact differences between the mice used in the TCR-CD3 complex compared to TCR-CD3 alone leads to the three studies. However, it is conceivable that there are a decrease in tyrosyl phosphorylation of a number of substrates differences in affinities which, in turn, affect the sensitivity of (47) . Moreover, CD5 has been implicated in negative regulation the individual mouse to the loss of a negative regulator such of TCR signaling, based on studies of TCR Tg mice in a CD5-as SHP-1. Interestingly in a recent study, it was reported deficient background. Indeed, such CD5-deficient mice show that motheaten viable (me v /me v ) mice, which carry a different changes in their thymocyte selection profiles (11) that resemble mutated allele of SHP-1 encoding a protein with decreased our observations of SHP-1-deficient mice. In this regard, the phosphatase activity, show increased deletion in response to role of CD5 in T cells might be analogous to that of CD22 in B an endogenous superantigen (40) . Together with our studies, cell signaling (48) (49) (50) (51) . Alternatively, it is well documented that this provides further evidence that SHP-1 is involved in setting SHP-1 becomes tyrosyl phosphorylated rapidly following T cell the threshold for negative selection. As discussed above, we activation (14) . This indicates its proximity to the PTKs that observed that the me/ϩ mouse produces an intermediate become activated upon TCR engagement and tyrosyl phenotype between ϩ/ϩ and me/me mice with a more phosphorylation might be a possible means of recruitment. detectable effect on positive than on negative selection (~50% Our observations (20 and the data presented above) strongly increase of the number of CD4 ϩ SP cells compared to 25%
suggest that SHP-1 functions upstream of src family kinases decrease of DP cells; Table 1 ). In the Plas et al. study, the such as Lck and Fyn. Since Zap-70 is downstream of Lck in loss of SHP-1 activity was generated by expression of a the TCR signaling cascade, it is feasible that the previously dominant negative mutant of SHP-1 in mice which, according described regulation of Zap-70 activity by SHP-1 (22) is, in to the authors, showed a 10 and 25% increase in total SHPfact, due to the regulation of Lck by SHP-1 with Zap-70 being 1 expression. Therefore, it is possible that their observation affected indirectly. Alternatively, both Lck and Zap-70 could be that only positive selection was affected might be due a direct targets of SHP-1. Given the previously established role decrease but not a total loss in SHP-1 activity, thereby more for Lck in regulating TCR-mediated events during thymocyte mimicking a me/ϩ mouse than a me/me mouse. development, it is possible that SHP-1 may regulate thymocyte SHP-1 has an analogous function in B cells, where it sets selection events by directly controlling activation of Lck. Howthe threshold for B cell receptor signaling (41) . In the me/me ever, additional evidence addressing whether Lck is a direct mouse, this signaling defect leads to a severe disruption of or a downstream target remains to be supplied. Further studies B cell development. In contrast, overall T cell development will be necessary to identify the specific downstream molecappears normal in me/me mice (20, [22] [23] [24] . It is well estabule(s) through which SHP-1 exerts its regulation of the TCR lished that src family kinases play a major role in lymphocyte signal strength during thymocyte development. Since the development (reviewed in 1,2) and our data strongly suggest selection of an appropriate repertoire of T cells is critical for that SHP-1 exerts its function as a negative regulator of TCR signaling by regulating Lck activity. Another protein normal immune responses and for preventing autoimmune dis-of the phosphotyosine phosphatase SH-PTP1 in murine T cells.
eases and immunodeficiencies, it will be important to identify 
